New York State Health Foundation

Shortcut Navigation:

Evaluation Technical Assistance for NYSHealth Grantees: Phase 7

  • By: NYSHealth
  • Date: May 2017
  • Priority Area: Other
  • Type: Grant Outcome Reports
  • Category: Grant Outcome Report
  • Grantee Name: New York University School of Medicine

Overview

Many grantees, especially smaller, non-academic organizations, often lack the experience, time, and resources needed to conduct and implement evaluations that are critical to effective program execution and sustainability. To address this need among its own grantees, in 2008, NYSHealth began funding a technical assistance initiative that offers additional support to grantees in strengthening the evaluation aspects of their projects. Under Phase 1 and 2 of this grant, the Center for Health Care Strategies led the project; beginning in 2011, an evaluation team from the New York University School of Medicine (NYU) has since overseen the initiative. The evaluation team has been providing direct assistance to grantees; holding training workshops for grantees; and offering one-on-one follow-up assistance to workshop participants. An online evaluation resource is also available for current grantees and potential NYSHealth applicants. Because of the success of the initiative, NYSHealth continues to provide technical assistance for new grantees and applicants each year.

Grantee: New York University School of Medicine

Dates:  November 2015 – October 2016

Grant Amount:  $151,579

Grantee Website: http://www.med.nyu.edu/

Grant ID: 15-03607


Outcomes and Lessons Learned:

  • Reached out to all new and eligible grantees to review the type of assistance needed;
  • Provided individualized assistance to 15 organizations;
  • Conducted two workshops, one in January 2016 and the other in June 2016; and
  • Continued to offer, promote, and monitor an online forum available to all new grantees and workshop participants during the grant period.

 

Related Grants:

Phases 1 & 2: $253,635 and $220,301
Phases 3 & 4: $166,979 and $151,670
Phases 5 & 6: $148,297 and $149,553
Phase 8: $154,690

Co-Funding and Additional Funds Leveraged: N/A